Tempfer CB - Search Results

1

The clinical value of serum concentrations of cancer antigen 125 in patients with primary fallopian tube carcinoma: a multicenter study.

Hefler LA, Rosen AC, Graf AH, Lahousen M, Klein M, Leodolter S, Reinthaller A, Kainz C, Tempfer CB. Hefler LA, et al. Among authors: tempfer cb. Cancer. 2000 Oct 1;89(7):1555-60. doi: 10.1002/1097-0142(20001001)89:7<1555::aid-cncr20>3.0.co;2-j. Cancer. 2000. PMID: 11013371

2

The prognostic value of immunohistochemically detected CD44v3 and CD44v6 expression in patients with surgically staged vulvar carcinoma: a multicenter study.

Hefler LA, Concin N, Mincham D, Thompson J, Swarte NB, van Eijkeren MA, Sie-Go DM, Hammond I, McCartney AJ, Tempfer CB, Speiser P. Hefler LA, et al. Among authors: tempfer cb. Cancer. 2002 Jan 1;94(1):125-30. doi: 10.1002/cncr.10206. Cancer. 2002. PMID: 11815968 Free article.

3

An interleukin-6 gene promoter polymorphism influences the biological phenotype of ovarian cancer.

Hefler LA, Grimm C, Ackermann S, Malur S, Radjabi-Rahat AR, Leodolter S, Beckmann MW, Zeillinger R, Koelbl H, Tempfer CB. Hefler LA, et al. Among authors: tempfer cb. Cancer Res. 2003 Jun 15;63(12):3066-8. Cancer Res. 2003. PMID: 12810629

4

Serum C-reactive protein as independent prognostic variable in patients with ovarian cancer.

Hefler LA, Concin N, Hofstetter G, Marth C, Mustea A, Sehouli J, Zeillinger R, Leipold H, Lass H, Grimm C, Tempfer CB, Reinthaller A. Hefler LA, et al. Among authors: tempfer cb. Clin Cancer Res. 2008 Feb 1;14(3):710-4. doi: 10.1158/1078-0432.CCR-07-1044. Clin Cancer Res. 2008. PMID: 18245530

5

Serum CD44 splice variants in cervical cancer patients.

Kainz C, Tempfer C, Winkler S, Sliutz G, Koelbl H, Reinthaller A. Kainz C, et al. Cancer Lett. 1995 Apr 14;90(2):231-4. doi: 10.1016/0304-3835(95)03708-5. Cancer Lett. 1995. PMID: 7537626

6

Serum evaluation of basic fibroblast growth factor in cervical cancer patients.

Sliutz G, Tempfer C, Obermair A, Reinthaller A, Gitsch G, Kainz C. Sliutz G, et al. Cancer Lett. 1995 Aug 1;94(2):227-31. doi: 10.1016/0304-3835(95)03853-o. Cancer Lett. 1995. PMID: 7634250

7

Prognostic value of immunohistochemically detected CD44 expression in patients with carcinoma of the vulva.

Tempfer C, Gitsch G, Haeusler G, Reinthaller A, Koelbl H, Kainz C. Tempfer C, et al. Cancer. 1996 Jul 15;78(2):273-7. doi: 10.1002/(SICI)1097-0142(19960715)78:2<273::AID-CNCR13>3.0.CO;2-T. Cancer. 1996. PMID: 8674003

8

CD44 is an independent prognostic factor in early-stage cervical cancer.

Speiser P, Wanner C, Tempfer C, Mittelböck M, Hanzal E, Bancher-Todesca D, Gitsch G, Reinthaller A, Kainz C. Speiser P, et al. Int J Cancer. 1997 Apr 22;74(2):185-8. doi: 10.1002/(sici)1097-0215(19970422)74:2<185::aid-ijc8>3.0.co;2-v. Int J Cancer. 1997. PMID: 9133453 Free article.

9

Serum M3/M21 in cervical cancer patients.

Sliutz G, Tempfer C, Hanzal E, Reinthaller A, Koelbl H, Zeillinger R, Kainz C. Sliutz G, et al. Eur J Cancer. 1997 May;33(6):973-5. doi: 10.1016/s0959-8049(96)00519-9. Eur J Cancer. 1997. PMID: 9291824

10

Serum M3/M21 in ovarian cancer patients.

Tempfer C, Hefler L, Haeusler G, Sliutz G, Hanzal E, Reinthaller A, Kainz CH. Tempfer C, et al. Br J Cancer. 1997;76(10):1387-9. doi: 10.1038/bjc.1997.565. Br J Cancer. 1997. PMID: 9374388 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

362 results

Search Page